Total raised
$18.7M
Last: Series D 2020-06
Stage
Series D
Founded
2009
Headcount
70
HQ
Jerusalem
Sector
Health Tech & Life Sciences
About
Accellix's mission is to provide quick and accurate flow cytometry results in a compact and easy-to-use platform designed for use on the manufacturing floor and at the point of care.
The Accellix platform enables its partners in the field of cell therapy to meet their critical quality control requirements as they advance life-changing therapies benefiting patients worldwide.
Funding history · 7 rounds · $18.7M total
2020-06
Series D
$9.5M
2014-06
Series B
$7.0M
2012-04
Undisclosed
$1.6M
2010-08
Undisclosed
$250K
2010-06
Debt Financing
$115K
2009-09
Undisclosed
$377K
2009-07
Seed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technologies
Platforms & InterfacesSoftware
Target customers
ConsumersDemographics & FamilyBabiesHealthcare & Life SciencesHealthcareProvidersLaboratories
Business model
B2B
Highlights
1 Patents
Tags
medical-technologieshospitalsreal-timemedical-deviceslaboratoriescritical-careblood-testbiomarkersdiagnosticsoperating-roomsdata-analyticssoftware-developmentdoctorsimmunotherapy